C5a receptor inhibitor avacopan in immunoglobulin A nephropathy—an open-label pilot study

Avacopan for the Treatment of ANCA-Associated Vasculitis

(2021) David R.W. Jayne et al.   NEW ENGLAND JOURNAL OF MEDICINE

After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.

(2020) Thomas Rauen et al.   KIDNEY INTERNATIONAL

Clinical use of complement, inflammation and fibrosis biomarkers in autoimmune glomerulonephritis.

(2020) Myriam Khalili et al.   Kidney International Reports

Proteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy

(2019) Aliza Thompson et al.   Clinical Journal of the American Society of Nephrology

High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study

(2019) Wen-yu Gong et al.   BMC Nephrology

Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathy

(2018) Rosanna Coppo et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

OUP accepted manuscript

(2018)   NEPHROLOGY DIALYSIS TRANSPLANTATION

OUP accepted manuscript

(2018)   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy

(2017) Jicheng Lv et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis

(2017) David R.W. Jayne et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary Glomerulonephritis

(2016) Supanat Worawichawong et al.   KIDNEY & BLOOD PRESSURE RESEARCH

The MEST score provides earlier risk prediction in lgA nephropathy

(2016) Sean J. Barbour et al.   KIDNEY INTERNATIONAL

Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study

(2015) V. Tesar et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy

(2015) Thomas Rauen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan

(2014) Takahito Moriyama et al.   PLoS One

C3a, C5a Renal Expression and Their Receptors are Correlated to Severity of IgA Nephropathy

(2013) Lu Liu et al.   JOURNAL OF CLINICAL IMMUNOLOGY

C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN

(2013) H. Xiao et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

IgA Nephropathy

(2013) Robert J. Wyatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Pathophysiology of IgA Nephropathy

(2011) H. Suzuki et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY